{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:03:03Z","timestamp":1789056183936,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hana Pharm, Seoul, Republic of Korea","award":["03-2022-0336"],"award-info":[{"award-number":["03-2022-0336"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>General anesthesia is often necessary for dental treatment of outpatients with mental disabilities. Rapid recovery and effective management of postoperative nausea and vomiting (PONV) are critical for outpatients. This study aimed to investigate the effect of transitioning from propofol to remimazolam with flumazenil reversal administered toward the end of surgery during propofol-based total intravenous anesthesia (TIVA) on recovery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Adults with mental disabilities scheduled to undergo dental treatment were randomly assigned to receive either propofol-based TIVA (Group P) or propofol-remimazolam-based TIVA with flumazenil reversal (Group PR). Propofol was replaced with remimazolam 1\u00a0h before the end of surgery in Group PR; moreover, 0.5\u00a0mg of flumazenil was administered after the neuromuscular blockade reversal agent. The primary outcome was the duration of stay in the post-anesthesia care unit (PACU). The secondary outcomes included time to eye-opening, time to extubation, occurrence of PONV, and quality of recovery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifty-four patients were included in this study. The duration of stay in the PACU in Group PR was significantly shorter than that in Group P (mean difference, 8.7\u00a0min; confidence interval [95% CI], 3.3\u201314.2; <jats:italic>P<\/jats:italic>\u2009=\u20090.002). Group PR exhibited a shorter time to eye opening (mean difference, 5.4\u00a0min; 95% CI, 3.3\u20138.1; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and time to extubation (mean difference, 5.5\u00a0min; 95% CI, 3.6\u20137.9; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) than Group P. Neither group required the administration of rescue analgesics, and the incidence of PONV was not reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Transitioning from propofol to remimazolam 1\u00a0h before the end of surgery followed by flumazenil reversal reduced the duration of stay in the PACU and the time to eye opening and extubation without affecting the incidence of PONV and quality of recovery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration number<\/jats:title>\n                <jats:p>Clinical Research Information Service (KCT0007794), Clinical trial first registration date: 12\/10\/2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-024-02526-5","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T05:01:54Z","timestamp":1713762114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of converting from propofol to remimazolam with flumazenil reversal on recovery from anesthesia in outpatients with mental disabilities: a randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Sooyoung","family":"Jeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myong-Hwan","family":"Karm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"2526_CR1","first-page":"134","volume":"45","author":"PT Haywood","year":"1998","unstructured":"Haywood PT, Karalliedde LD. General anesthesia for disabled patients in dental practice. Anesth Prog. 1998;45:134\u20138.","journal-title":"Anesth Prog"},{"key":"2526_CR2","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.4317\/jced.59266","volume":"14","author":"CF M\u00e1rquez-Arrico","year":"2022","unstructured":"M\u00e1rquez-Arrico CF, Talav\u00e1n-Serna J, Silvestre FJ, Vi\u00f1oles J, Rodr\u00edguez-Mart\u00ednez S, Silvestre-Rangil J. Dental treatment under general anesthesia in mentally disabled patients based on an ambulatory surgery model: a case-control study. J Clin Exp Dent. 2022;14:e192\u20138.","journal-title":"J Clin Exp Dent"},{"key":"2526_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jicd.12174","volume":"7","author":"SK Mallineni","year":"2016","unstructured":"Mallineni SK, Yiu CKY. Dental treatment under general anesthesia for special-needs patients: analysis of the literature. J Investig Clin Dent. 2016;7:325\u201331.","journal-title":"J Investig Clin Dent"},{"key":"2526_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2344\/0003-3006-62.1.8","volume":"62","author":"S Maeda","year":"2015","unstructured":"Maeda S, Tomoyasu Y, Higuchi H, Ishii-Maruhama M, Egusa M, Miyawaki T. Independent predictors of delay in emergence from general anesthesia. Anesth Prog. 2015;62:8\u201313.","journal-title":"Anesth Prog"},{"key":"2526_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.17245\/jdapm.2021.21.3.219","volume":"21","author":"J Choi","year":"2021","unstructured":"Choi J, Kim S. Delayed awakening time from general anesthesia for dental treatment of patients with disabilities. J Dent Anesth Pain Med. 2021;21:219\u201326.","journal-title":"J Dent Anesth Pain Med"},{"key":"2526_CR6","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/bja\/aes426","volume":"110","author":"I Bergmann","year":"2013","unstructured":"Bergmann I, G\u00f6hner A, Crozier TA, Hesjedal B, Wiese CH, Popov AF, et al. Surgical pleth index-guided remifentanil administration reduces remifentanil and propofol consumption and shortens recovery times in outpatient anaesthesia. Br J Anaesth. 2013;110:622\u20138.","journal-title":"Br J Anaesth"},{"key":"2526_CR7","doi-asserted-by":"crossref","unstructured":"Gupta A, Stierer T, Zuckerman R, Sakima N, Parker SD, Fleisher LA. Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg. 2004;98:632\u2009\u2013\u200941, table of contents.","DOI":"10.1213\/01.ANE.0000103187.70627.57"},{"key":"2526_CR8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/ALN.0b013e31818ddba8","volume":"109","author":"PF White","year":"2008","unstructured":"White PF. Propofol: its role in changing the practice of anesthesia. Anesthesiology. 2008;109:1132\u20136.","journal-title":"Anesthesiology"},{"key":"2526_CR9","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2165\/00003088-200241110-00001","volume":"41","author":"JM Bailey","year":"2002","unstructured":"Bailey JM. Context-sensitive half-times: what are they and how valuable are they in anaesthesiology? Clin Pharmacokinet. 2002;41:793\u20139.","journal-title":"Clin Pharmacokinet"},{"key":"2526_CR10","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/00000542-199203000-00003","volume":"76","author":"MA Hughes","year":"1992","unstructured":"Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology. 1992;76:334\u201341.","journal-title":"Anesthesiology"},{"key":"2526_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17085\/apm.21115","volume":"17","author":"KM Kim","year":"2022","unstructured":"Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med (Seoul). 2022;17:1\u201311.","journal-title":"Anesth Pain Med (Seoul)"},{"key":"2526_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bja.2021.03.028","volume":"127","author":"JR Sneyd","year":"2021","unstructured":"Sneyd JR, Gambus PL, Rigby-Jones AE. Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative review. Br J Anaesth. 2021;127:41\u201355.","journal-title":"Br J Anaesth"},{"key":"2526_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/phar.1806","volume":"36","author":"AM Wesolowski","year":"2016","unstructured":"Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36:1021\u20137.","journal-title":"Pharmacotherapy"},{"key":"2526_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020;34:543\u201353.","journal-title":"J Anesth"},{"key":"2526_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/jcm12010257","volume":"12","author":"Y Pan","year":"2022","unstructured":"Pan Y, Chen M, Gu F, Chen J, Zhang W, Huang Z, et al. Comparison of remimazolam-flumazenil versus propofol for rigid bronchoscopy: a prospective randomized controlled trial. J Clin Med. 2022;12:257.","journal-title":"J Clin Med"},{"key":"2526_CR16","doi-asserted-by":"publisher","first-page":"110955","DOI":"10.1016\/j.jclinane.2022.110955","volume":"82","author":"JY Choi","year":"2022","unstructured":"Choi JY, Lee HS, Kim JY, Han DW, Yang JY, Kim MJ, et al. Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: a randomized non-inferiority trial. J Clin Anesth. 2022;82:110955.","journal-title":"J Clin Anesth"},{"key":"2526_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12871-023-02104-1","volume":"23","author":"HJ Lee","year":"2023","unstructured":"Lee HJ, Lee HB, Kim YJ, Cho HY, Kim WH, Seo JH. Comparison of the recovery profile of remimazolam with flumazenil and propofol anesthesia for open thyroidectomy. BMC Anesthesiol. 2023;23:147.","journal-title":"BMC Anesthesiol"},{"key":"2526_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00540-020-02776-w","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34:491\u2013501.","journal-title":"J Anesth"},{"key":"2526_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2147\/IJGM.S345390","volume":"15","author":"F Shi","year":"2022","unstructured":"Shi F, Chen Y, Li H, Zhang Y, Zhao T. Efficacy and safety of remimazolam tosilate versus propofol for general anesthesia in cirrhotic patients undergoing endoscopic variceal ligation. Int J Gen Med. 2022;15:583\u201391.","journal-title":"Int J Gen Med"},{"key":"2526_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4097\/kja.22441","volume":"76","author":"Y Suzuki","year":"2023","unstructured":"Suzuki Y, Kawashima S, Makino H, Doi M, Nakajima Y. Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study. Korean J Anesthesiol. 2023;76:143\u201351.","journal-title":"Korean J Anesthesiol"},{"key":"2526_CR21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/BF03011083","volume":"42","author":"F Chung","year":"1995","unstructured":"Chung F. Discharge criteria\u2013a new trend. Can J Anaesth. 1995;42:1056\u20138.","journal-title":"Can J Anaesth"},{"key":"2526_CR22","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.bja.2020.06.040","volume":"125","author":"S Yoon","year":"2020","unstructured":"Yoon S, Joo H, Oh YM, Lee J, Bahk JH, Lee HJ. Validation and clinical utility of the Korean version of the quality of Recovery-15 with enhanced recovery after surgery: a prospective observational cohort study. Br J Anaesth. 2020;125:614\u201321.","journal-title":"Br J Anaesth"},{"key":"2526_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4097\/kja.20435","volume":"74","author":"JH Lee","year":"2021","unstructured":"Lee JH, Ki M, Choi S, Woo CJ, Kim D, Lim H, et al. Validity and reliability of the Korean version of the quality of Recovery-15 questionnaire. Korean J Anesthesiol. 2021;74:142\u20139.","journal-title":"Korean J Anesthesiol"},{"key":"2526_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s10877-020-00631-7","volume":"35","author":"S Yoon","year":"2021","unstructured":"Yoon S, Park JB, Lee J, Lee HC, Bahk JH, Cho YJ. Relationship between blood pressure stability and mortality in cardiac surgery patients: retrospective cohort study. J Clin Monit Comput. 2021;35:931\u201342.","journal-title":"J Clin Monit Comput"},{"key":"2526_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF01143186","volume":"20","author":"JR Varvel","year":"1992","unstructured":"Varvel JR, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm. 1992;20:63\u201394.","journal-title":"J Pharmacokinet Biopharm"},{"key":"2526_CR26","doi-asserted-by":"publisher","first-page":"7030","DOI":"10.1038\/s41598-017-07664-0","volume":"7","author":"HC Lee","year":"2017","unstructured":"Lee HC, Ryu HG, Jung CW. Performance measurement of intraoperative systolic arterial pressure to predict in-hospital mortality in adult liver transplantation. Sci Rep. 2017;7:7030.","journal-title":"Sci Rep"},{"key":"2526_CR27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1213\/ANE.0b013e3182a705ae","volume":"117","author":"MT Worthington","year":"2013","unstructured":"Worthington MT, Antonik LJ, Goldwater DR, Lees JP, Wilhelm-Ogunbiyi K, Borkett KM, et al. A phase ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy. Anesth Analg. 2013;117:1093\u2013100.","journal-title":"Anesth Analg"},{"key":"2526_CR28","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.clinthera.2020.02.006","volume":"42","author":"X Chen","year":"2020","unstructured":"Chen X, Sang N, Song K, Zhong W, Wang H, Jiang J, et al. Psychomotor recovery following remimazolam-induced sedation and the effectiveness of flumazenil as an antidote. Clin Ther. 2020;42:614\u201324.","journal-title":"Clin Ther"},{"key":"2526_CR29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00540-021-02915-x","volume":"35","author":"T Yamamoto","year":"2021","unstructured":"Yamamoto T, Kurabe M, Kamiya Y. Re-sleeping after reversal of remimazolam by flumazenil. J Anesth. 2021;35:322.","journal-title":"J Anesth"},{"key":"2526_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00540-022-03107-x","volume":"37","author":"K Masui","year":"2023","unstructured":"Masui K. Caution!! Reappearance of remimazolam effect after a flumazenil bolus: a larger bolus of flumazenil and a lower total remimazolam clearance are higher risks. J Anesth. 2023;37:1\u20135.","journal-title":"J Anesth"},{"key":"2526_CR31","first-page":"967","volume":"80","author":"A Hvarfner","year":"1995","unstructured":"Hvarfner A, Hammas B, Th\u00f6rn SE, Wattwil M. The influence of propofol on vomiting induced by apomorphine. Anesth Analg. 1995;80:967\u20139.","journal-title":"Anesth Analg"},{"key":"2526_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1365-2044.1988.tb05551.x","volume":"43","author":"JS McCollum","year":"1988","unstructured":"McCollum JS, Milligan KR, Dundee JW. The antiemetic action of propofol. Anaesthesia. 1988;43:239\u201340.","journal-title":"Anaesthesia"},{"key":"2526_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/bja\/78.3.247","volume":"78","author":"M Tram\u00e8r","year":"1997","unstructured":"Tram\u00e8r M, Moore A, McQuay H. Propofol anaesthesia and postoperative nausea and vomiting: quantitative systematic review of randomized controlled studies. Br J Anaesth. 1997;78:247\u201355.","journal-title":"Br J Anaesth"},{"key":"2526_CR34","doi-asserted-by":"publisher","first-page":"e33249","DOI":"10.1097\/MD.0000000000033249","volume":"102","author":"H Xiao","year":"2023","unstructured":"Xiao H, Liu M, Man Y, Wei Y, Ji F. Effect of low-dose propofol combined with dexamethasone on the prevention of postoperative nausea and vomiting in gynaecological day surgery under remimazolam-based general anesthesia. Med (Baltim). 2023;102:e33249.","journal-title":"Med (Baltim)"},{"key":"2526_CR35","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2147\/DDDT.S359496","volume":"16","author":"Y Mao","year":"2022","unstructured":"Mao Y, Guo J, Yuan J, Zhao E, Yang J. Quality of recovery after general anesthesia with remimazolam in patients\u2019 undergoing urologic surgery: a randomized controlled trial comparing remimazolam with propofol. Drug Des Devel Ther. 2022;16:1199\u2013209.","journal-title":"Drug Des Devel Ther"},{"key":"2526_CR36","doi-asserted-by":"publisher","first-page":"1101728","DOI":"10.3389\/fphar.2023.1101728","volume":"14","author":"CC Ko","year":"2023","unstructured":"Ko CC, Hung KC, Illias AM, Chiu CC, Yu CH, Lin CM, et al. The use of remimazolam versus propofol for induction and maintenance of general anesthesia: a systematic review and meta-analysis. Front Pharmacol. 2023;14:1101728.","journal-title":"Front Pharmacol"},{"key":"2526_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00540-021-03030-7","volume":"36","author":"K Shirozu","year":"2022","unstructured":"Shirozu K, Nobukuni K, Tsumura S, Imura K, Nakashima K, Takamori S, et al. Neurological sedative indicators during general anesthesia with remimazolam. J Anesth. 2022;36:194\u2013200.","journal-title":"J Anesth"},{"key":"2526_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40981-021-00485-1","volume":"8","author":"M Miyanishi","year":"2022","unstructured":"Miyanishi M, Yaguramaki T, Maehara Y, Nagata O. Three cases of difficulty in achieving definitive loss of consciousness with remimazolam. JA Clin Rep. 2022;8:4.","journal-title":"JA Clin Rep"},{"key":"2526_CR39","first-page":"e01460","volume":"15","author":"H Yoshikawa","year":"2021","unstructured":"Yoshikawa H, Hosokawa M, Kashima Y, Oki S, Masui K. Remimazolam tolerance in long-term benzodiazepine users: a case report of 2 cases. Pract. 2021;15:e01460.","journal-title":"Pract"},{"key":"2526_CR40","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11096-023-01568-y","volume":"45","author":"S Lyu","year":"2023","unstructured":"Lyu S, Deng Q, Lin W, Wu X. Randomized controlled trial for anesthesia during gastroscopy: interactions remimazolam and propofol in combination with sufentanil. Int J Clin Pharm. 2023;45:857\u201363.","journal-title":"Int J Clin Pharm"},{"key":"2526_CR41","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2147\/DDDT.S406514","volume":"17","author":"H Tan","year":"2023","unstructured":"Tan H, Lou AF, Wu JE, Chen SZ, Qian XW. Determination of the 50% and 95% effective dose of remimazolam combined with propofol for intravenous sedation during day-surgery hysteroscopy. Drug Des Devel Ther. 2023;17:1753\u201361.","journal-title":"Drug Des Devel Ther"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02526-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-024-02526-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02526-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T05:01:59Z","timestamp":1713762119000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-024-02526-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2526"],"URL":"https:\/\/doi.org\/10.1186\/s12871-024-02526-5","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"12 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board of the Seoul National University Dental Hospital (IRB # CME22002; date of approval: August 11, 2022) and registered with the Clinical Research Information Service (number: KCT0007794; date of registration: October 12, 2022). This study adhered to the principles outlined in the Declaration of Helsinki, and written informed consent was obtained from the parents or legally authorized representatives of the patients before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}